Endothelial Glycocalyx Damage in Brain Death Organ Donors

Organ Transplant Failure or Rejection Clinical Trial

Official title:
Endothelial Glycocalyx Status and Damage in Brain Death Organ Donors

Status Recruiting

Clinical Trial Summary

The study aims the assessment of endothelial glycocalyx (EG) degradation in deceased organ donors. There is a lack of organs for the transplantation program. By the description of the EG status, we can open room for organ optimization before transplantation and improve the organ function after transplantation in marginal donors.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Brain Death
Brain Injuries
Hypoxia
Organ Donors
Organ Transplant Failure or Rejection

Clinical Trial Details

NCT number	NCT05609123
Study type	Observational
Source	University Hospital Hradec Kralove
Contact	David Astapenko, MD, PhD
Phone	+420495833218
Email	david.astapenko@fnhk.cz
Status	Recruiting
Phase
Start date	January 1, 2022
Completion date	June 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04789213` - Mortality, Morbidity and Risk Factors of Liver Retransplantation
Terminated	`NCT03439995` - Goal of Open Lung Ventilation in Donors	N/A
Completed	`NCT02525510` - Deceased Organ Donor Interventions to Protect Kidney Graft Function	N/A
Recruiting	`NCT05148715` - Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)	Phase 2